Big Pharma loves a good acquisition - and this company fits the type

Could this biotech spark Big Pharma's next multibillion-dollar move?

After 50 Years of Chemo, One Biotech Looks to Lead the Next Cancer Breakthrough

For decades, chemotherapy has come at a heavy cost.

Now, one biotech’s breakthrough could finally change that.

With early data showing precision without poison, this may be one of the most meaningful stories in biotech.

Message Disclaimer
This is a paid placement email where Sandpiper Marketing Group, LLC is being compensated by i2i Media Group, LLC up to three dollars per click and may exceed three thousand dollars per week (defined as Monday through Friday when the email was sent) for placement of specific advertisements contained in this email newsletter. Sandpiper Marketing Group, LLC and its principles have not evaluated or researched this content and do not own any of the securities mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser’s website for additional information, including their relationship with any mentioned security.